Form D · Biotechnology
Noveome Biotherapeutics, Inc.
Pittsburgh, PA · CIK 0001478304
Offering snapshot reported Aug 27, 2026 · SEC filing
- Reported sold
- $6.75M Offering amount: $15M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 12, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 27, 2026 | Initial | $6,750,503 | No comparison | 6 | SEC filing |
| Aug 8, 2024 | Amendment | $36,184,531 | $15,494,051vs Aug 17, 2023 | 66 | SEC filing |
| Aug 17, 2023 | Initial | $20,690,480 | No comparison | 59 | SEC filing |
| Oct 2, 2020 | Initial | $870,000 | No comparison | 7 | SEC filing |
| Apr 22, 2019 | Amendment | $15,000,000 | $12,631,078vs Jan 24, 2018 | 39 | SEC filing |
| Jan 24, 2018 | Initial | $2,368,922 | No comparison | 10 | SEC filing |
| Apr 14, 2016 | Amendment | $2,158,479 | $447,683vs Jan 13, 2016 | 39 | SEC filing |
| Jan 13, 2016 | Initial | $1,710,796 | No comparison | 33 | SEC filing |
| Jul 12, 2012 | Initial | $570,746 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-595661
Convertible promissory notes
Source: Form D, filed Aug 27, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| A. Clarke Atwell | Director, Executive |
| Larry Brown | Executive |
| Terence Golden | Director |
| William Golden | Director, Executive |
| Houman Hemmati | Director |
| Michael Kaufman | Director |
| Eric Keller | Director, Executive |
| Gretchen Kraemer | Executive |
| Robert Langer | Director |
| John Mc Arthur | Director |
| Craig Nemiroff | Director |
| Ronald Poropatich | Director |
| Karin Potoka | Executive |
| George Sing | Director, Executive |
| Donald Wagner | Director |
| Patrick Welch | Director, Executive |
| Patric Welch | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
620 Alpha Drive Suite 2
Pittsburgh, PA, 15238
Phone: 412-799-6157
Pittsburgh, PA, 15238
Phone: 412-799-6157